Will Aurora Cannabis Inc (ACB) Beat the Rest of the Stocks in the Healthcare Sector?

Tuesday, August 4, 2020 3:28 PM | InvestorsObserver Analysts

Aurora Cannabis Inc (ACB) is near the bottom in its sector according to InvestorsObserver.

ACB gets an overall rating of 16. That means it scores higher than 16% of stocks.

Aurora Cannabis Inc gets a 21 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.

Overall Score - 16
ACB has an Overall Score of 16. Find out what this means to you and get the rest of the rankings on ACB!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Aurora Cannabis Inc Stock Today?

Aurora Cannabis Inc (ACB) stock is trading at $10.75 as of 3:24 PM on Tuesday, Aug 4, a gain of $0.32, or 3.07% from the previous closing price of $10.43. The stock has traded between $10.21 and $10.75 so far today. Volume today is low. So far 1,744,545 shares have traded compared to average volume of 3,776,257 shares.

To see the top 5 stocks in Healthcare click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Sector Update: Afternoon Recovery for Health Care Stocks

Sector Update: Health Care

Where Will Celldex Therapeutics, Inc. (CLDX) Stock Go Next After It Is Up 23.13% in a Week?

Seelos Therapeutics Inc (SEEL) Stock: What Does the Chart Say?

Related Companies